UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Crizotinib therapy for advanced lung adenocarcinoma and a ROS1 rearrangement: results from the EUROS1 cohort

Journal of clinical oncology, 2015-03, Vol.33 (9), p.992-999

2015

Volltextzugriff (PDF)

Targeted Therapy in Advanced and Metastatic Non-Small Cell Lung Cancer. An Update on Treatment of the Most Important Actionable Oncogenic Driver Alterations

Cancers, 2021-02, Vol.13 (4), p.804

2021

Volltextzugriff (PDF)

Tumor mutational burden assessed by targeted NGS predicts clinical benefit from immune checkpoint inhibitors in non‐small cell lung cancer

The Journal of pathology, 2020-01, Vol.250 (1), p.19-29

2020

Volltextzugriff (PDF)

Tumor-associated B cells and humoral immune response in head and neck squamous cell carcinoma

Oncoimmunology, 2019-03, Vol.8 (3), p.1535293-1535293

2019

Volltextzugriff (PDF)

Resection of isolated brain metastases in non-small cell lung cancer (NSCLC) patients – evaluation of outcome and prognostic factors: A retrospective multicenter study

PloS one, 2021-06, Vol.16 (6), p.e0253601

2021

Volltextzugriff (PDF)

Local tumor microbial signatures and response to checkpoint blockade in non-small cell lung cancer

Oncoimmunology, 2021-01, Vol.10 (1), p.1988403-1988403

2021

Volltextzugriff (PDF)

Influenza vaccination of cancer patients during PD-1 blockade induces serological protection but may raise the risk for immune-related adverse events

Journal for immunotherapy of cancer, 2018-05, Vol.6 (1), p.40-40, Article 40

2018

Volltextzugriff (PDF)

MicroRNA-106a targets autophagy and enhances sensitivity of lung cancer cells to Src inhibitors

Lung cancer (Amsterdam, Netherlands), 2017-05, Vol.107, p.73-83

2017

Volltextzugriff (PDF)

Measurement of epithelial thickness within the oral cavity using optical coherence tomography

Head & neck, 2012-12, Vol.34 (12), p.1777-1781

2012

Volltextzugriff (PDF)

Oncologist recommendation matters!—Predictors of psycho‐oncological service uptake in oncology outpatients

Psycho-oncology (Chichester, England), 2019-02, Vol.28 (2), p.351-357

2019

Volltextzugriff (PDF)

3-weekly or weekly cisplatin concurrently with radiotherapy for patients with squamous cell carcinoma of the head and neck - a multicentre, retrospective analysis

Radiation oncology (London, England), 2019-02, Vol.14 (1), p.32-10, Article 32

2019

Volltextzugriff (PDF)

Epigenetic Therapy in Lung Cancer - Role of microRNAs

Frontiers in oncology, 2013-01, Vol.3, p.158

Rothschild, Sacha I

2013

Volltextzugriff (PDF)

Immunotherapy in head and neck cancer - scientific rationale, current treatment options and future directions

Swiss medical weekly, 2018-05, Vol.148, p.w14625

2018

Volltextzugriff (PDF)

Lenvatinib in Advanced Radioiodine-Refractory Thyroid Cancer - A Retrospective Analysis of the Swiss Lenvatinib Named Patient Program

Journal of Cancer, 2018, Vol.9 (2), p.250-255

2018

Volltextzugriff (PDF)

B cells in esophago-gastric adenocarcinoma are highly differentiated, organize in tertiary lymphoid structures and produce tumor-specific antibodies

Oncoimmunology, 2019-01, Vol.8 (1), p.e1512458-e1512458

2019

Volltextzugriff (PDF)

Single-Center Experience with a Targeted Next Generation Sequencing Assay for Assessment of Relevant Somatic Alterations in Solid Tumors

Neoplasia (New York, N.Y.), 2017-03, Vol.19 (3), p.196-206

2017

Volltextzugriff (PDF)

Real-World Data of Combined Immunochemotherapy in Patients With Nonsquamous Advanced NSCLC. A Single-Center Retrospective Study

JTO clinical and research reports, 2023-05, Vol.4 (5), p.100509-100509, Article 100509

2023

Volltextzugriff (PDF)

Prospective, observational practice survey of applied skin care and management of cetuximab-related skin reactions: PROSKIN study

Cancer chemotherapy and pharmacology, 2019-10, Vol.84 (4), p.881-889

2019

Volltextzugriff (PDF)

Culture and Drug Profiling of Patient Derived Malignant Pleural Effusions for Personalized Cancer Medicine

PloS one, 2016-08, Vol.11 (8), p.e0160807-e0160807

2016

Volltextzugriff (PDF)

Targeted Therapies in Non-Small Cell Lung Cancer-Beyond EGFR and ALK

Cancers, 2015-05, Vol.7 (2), p.930-949

Rothschild, Sacha I

2015

Volltextzugriff (PDF)

SwissMTB: establishing comprehensive molecular cancer diagnostics in Swiss clinics

BMC medical informatics and decision making, 2018-10, Vol.18 (1), p.89-18, Article 89

2018

Volltextzugriff (PDF)

Treatment, Outcome and Prognostic Factors in Renal Cell Carcinoma - A Single Center Study (2000-2010)

Journal of Cancer, 2016-01, Vol.7 (8), p.921-927

2016

Volltextzugriff (PDF)

KRAS and Immune Checkpoint Inhibitors—Serendipity Raising Expectations

Journal of thoracic oncology, 2019-06, Vol.14 (6), p.951-954

Rothschild, Sacha I.

2019

Volltextzugriff (PDF)

First Indicator of Relapse in Testicular Cancer and Implications for Follow-up: Analysis of the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS)

European urology open science (Online), 2024-10, Vol.68, p.68-74

2024

Volltextzugriff (PDF)

1 – 25 von 173

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(158)
Mit Volltextzugriff
(145)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(102)
Life Sciences & Biomedicine
(99)
Oncology
(87)
Humans
(54)
Male
(34)
Female
(32)
Aged
(27)
Middle Aged
(27)
Lung Cancer
(26)
Adult
(22)
Immunotherapy
(22)
Lung Neoplasms - Drug Therapy
(21)
Respiratory System
(20)
Chemotherapy
(19)
Metastasis
(18)
Patients
(18)
Cancer
(17)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(15)
Medicine
(15)
Aged, 80 And Over
(14)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Crizotinib therapy for advanced lung adenocarcinoma and a ROS1 rearrangement: results from the EUROS1 cohort

Targeted Therapy in Advanced and Metastatic Non-Small Cell Lung Cancer. An Update on Treatment of the Most Important Actionable Oncogenic Driver Alterations

Tumor mutational burden assessed by targeted NGS predicts clinical benefit from immune checkpoint inhibitors in non‐small cell lung cancer

Tumor-associated B cells and humoral immune response in head and neck squamous cell carcinoma

Resection of isolated brain metastases in non-small cell lung cancer (NSCLC) patients – evaluation of outcome and prognostic factors: A retrospective multicenter study

Local tumor microbial signatures and response to checkpoint blockade in non-small cell lung cancer

Influenza vaccination of cancer patients during PD-1 blockade induces serological protection but may raise the risk for immune-related adverse events

MicroRNA-106a targets autophagy and enhances sensitivity of lung cancer cells to Src inhibitors

Measurement of epithelial thickness within the oral cavity using optical coherence tomography

Oncologist recommendation matters!—Predictors of psycho‐oncological service uptake in oncology outpatients

3-weekly or weekly cisplatin concurrently with radiotherapy for patients with squamous cell carcinoma of the head and neck - a multicentre, retrospective analysis

Epigenetic Therapy in Lung Cancer - Role of microRNAs

Immunotherapy in head and neck cancer - scientific rationale, current treatment options and future directions

Lenvatinib in Advanced Radioiodine-Refractory Thyroid Cancer - A Retrospective Analysis of the Swiss Lenvatinib Named Patient Program

B cells in esophago-gastric adenocarcinoma are highly differentiated, organize in tertiary lymphoid structures and produce tumor-specific antibodies

Single-Center Experience with a Targeted Next Generation Sequencing Assay for Assessment of Relevant Somatic Alterations in Solid Tumors

Real-World Data of Combined Immunochemotherapy in Patients With Nonsquamous Advanced NSCLC. A Single-Center Retrospective Study

Prospective, observational practice survey of applied skin care and management of cetuximab-related skin reactions: PROSKIN study

Culture and Drug Profiling of Patient Derived Malignant Pleural Effusions for Personalized Cancer Medicine

Targeted Therapies in Non-Small Cell Lung Cancer-Beyond EGFR and ALK

SwissMTB: establishing comprehensive molecular cancer diagnostics in Swiss clinics

SAKK 16/14: Durvalumab in Addition to Neoadjuvant Chemotherapy in Patients With Stage IIIA(N2) Non–Small-Cell Lung Cancer—A Multicenter Single-Arm Phase II Trial

Treatment, Outcome and Prognostic Factors in Renal Cell Carcinoma - A Single Center Study (2000-2010)

KRAS and Immune Checkpoint Inhibitors—Serendipity Raising Expectations

First Indicator of Relapse in Testicular Cancer and Implications for Follow-up: Analysis of the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS)

Suchergebnisse filtern